FDA.reportPublic FDA data

Application 202868

Type
ANDA
Sponsor
GLENMARK PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001POTASSIUM CHLORIDEPOTASSIUM CHLORIDECAPSULE, EXTENDED RELEASE;ORAL10MEQNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
16714-824Potassium ChloridePotassium ChlorideNorthstar Rx LLCANDACurrent
60687-533Potassium ChloridePotassium ChlorideAmerican Health PackagingANDACurrent
68001-396Potassium ChloridePotassium ChlorideBluePoint LaboratoriesANDACurrent
68071-3153Potassium ChloridePotassium ChlorideNuCare Pharmaceuticals, Inc.ANDACurrent
68071-3153Potassium ChloridePotassium ChlorideNuCare Pharmaceuticals, Inc.ANDACurrent
68071-3153Potassium ChloridePotassium ChlorideNuCare Pharmaceuticals, Inc.ANDACurrent
68462-357Potassium ChloridePotassium ChlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
70518-1203Potassium ChloridePotassium ChlorideREMEDYREPACK INC.ANDACurrent
70518-1203Potassium ChloridePotassium ChlorideREMEDYREPACK INC.ANDACurrent
70518-1203Potassium ChloridePotassium ChlorideREMEDYREPACK INC.ANDACurrent
70518-1203Potassium ChloridePotassium ChlorideREMEDYREPACK INC.ANDACurrent
70518-1203Potassium ChloridePotassium ChlorideREMEDYREPACK INC.ANDACurrent
70934-765Potassium ChloridePotassium ChlorideDenton Pharma, Inc. dba Northwind PharmaceuticalsANDACurrent